Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary (929) Apply Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Paediatric investigation plans Remove Paediatric investigation plans filter Maximum residue limits Remove Maximum residue limits filter Referrals Remove Referrals filter European public assessment reports (EPAR) (1758) Apply European public assessment reports (EPAR) filter Summaries of opinion (47) Apply Summaries of opinion filter Withdrawn applications (308) Apply Withdrawn applications filter Orphan designations (2782) Apply Orphan designations filter Periodic safety update report single assessments (2590) Apply Periodic safety update report single assessments filter Shortages (50) Apply Shortages filter Direct healthcare professional communication (109) Apply Direct healthcare professional communication filter Opinions on medicines for use outside EU (15) Apply Opinions on medicines for use outside EU filter

PIP decision type

P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) (668) Apply P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) filter PM: decision on the application for modification of an agreed PIP (902) Apply PM: decision on the application for modification of an agreed PIP filter RP: decision refers to a refusal on a proposed Paediatric Investigation Plan (19) Apply RP: decision refers to a refusal on a proposed Paediatric Investigation Plan filter RPM: decision refers to a refusal on the application for modification of an agreed PIP (22) Apply RPM: decision refers to a refusal on the application for modification of an agreed PIP filter RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) (36) Apply RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) filter W: decision granting a waiver in all age groups for all conditions or indications (1085) Apply W: decision granting a waiver in all age groups for all conditions or indications filter

PIP condition / indication

Pharmaceutical form(s)

Route(s) of administration

Decision date

From:

To:

PIP compliance check

Yes (299) Apply Yes filter

Date of opinion

From:

To:

Compliance procedure number

Referral name

Referral status

European Commission final decision (419) Apply European Commission final decision filter CMDh final position (19) Apply CMDh final position filter Procedure started (4) Apply Procedure started filter

Referral safety status

Yes (97) Apply Yes filter

Referral type

Article 31 referrals (125) Apply Article 31 referrals filter Article 29(4) referrals (121) Apply Article 29(4) referrals filter Article 30 referrals (96) Apply Article 30 referrals filter Article 20 procedures (28) Apply Article 20 procedures filter Article 6(12) referrals (prior to January 2010) (21) Apply Article 6(12) referrals (prior to January 2010) filter Article 107 procedures (prior to July 2012) (15) Apply Article 107 procedures (prior to July 2012) filter Article 29 paediatrics (9) Apply Article 29 paediatrics filter Article 36 referrals (prior to July 2012) (9) Apply Article 36 referrals (prior to July 2012) filter Article 107i procedures (9) Apply Article 107i procedures filter Article 13 referrals (6) Apply Article 13 referrals filter Article 6(13) referrals (prior to January 2010) (5) Apply Article 6(13) referrals (prior to January 2010) filter Article 5(11) referrals (prior to January 2010) (2) Apply Article 5(11) referrals (prior to January 2010) filter

Referral reference number

Referral decision making model

PRAC-CAT-CHMP-EC (1) Apply PRAC-CAT-CHMP-EC filter PRAC-CHMP-EC (32) Apply PRAC-CHMP-EC filter PRAC-CMDh (38) Apply PRAC-CMDh filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (13) Apply Centrally and nationally authorised products (mixed) filter Centrally authorised product(s) (26) Apply Centrally authorised product(s) filter Nationally authorised product(s) (67) Apply Nationally authorised product(s) filter

Referral PRAC recommendation

No further action (1) Apply No further action filter Revocation (4) Apply Revocation filter Risk minimisation measures (35) Apply Risk minimisation measures filter Suspension (9) Apply Suspension filter Variation (14) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Medicine type

Accelerated assessment (44) Apply Accelerated assessment filter Additional monitoring (212) Apply Additional monitoring filter Biosimilar (1) Apply Biosimilar filter Conditional approval (33) Apply Conditional approval filter Exceptional circumstances (16) Apply Exceptional circumstances filter Generic (3) Apply Generic filter Orphan medicine (99) Apply Orphan medicine filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

3178 results

Remove all filtersRemove all filters

Medicine Maximum residue limits Remove Maximum residue limits filter Paediatric investigation plans Remove Paediatric investigation plans filter Referrals Remove Referrals filter

Categories Human Remove Human filter

Sort by

List item

Referral: Varilrix

live attenuated varicella virus (OKA strain), Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/02/2021, EC decision date: 21/04/2021, Last updated: 09/06/2021
List item

Referral: Angiotensin-II-receptor antagonists (sartans) containing a tetrazole group

valsartan, candesartan, irbesartan, losartan, olmesartan, associated names: Karvezide, Karvea, Irbesartan/Hydrochlorothiazide Teva, Irbesartan Zentiva (previously Irbesartan Winthrop), Irbesartan Teva, Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop), Ifirmasta (previously Irbesartan Krka), Ifirmacombi, Aprovel, Neparvis, Exforge, Exforge HCT, Entresto, Dafiro HCT, Dafiro, Copalia HCT, Copalia, Amlodipine / Valsartan Mylan , CoAprovel, Article 31 referrals
Status: European Commission final decision, opinion/position date: 12/11/2020, EC decision date: 19/02/2021, Last updated: 19/03/2021
List item

Referral: Ranitidine-containing medicinal products

ranitidine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 17/09/2020, EC decision date: 24/11/2020, Last updated: 17/02/2021
List item

Referral: Ulipristal acetate 5mg medicinal products

ulipristal acetate, associated names: Esmya, Ulipristal Acetate Gedeon Richter, Article 31 referrals
Status: European Commission final decision, opinion/position date: 12/11/2020, EC decision date: 11/01/2021, Last updated: 03/02/2021
List item

Referral: Picato

ingenol mebutate, associated names: Picato, Article 20 procedures
Status: European Commission final decision, opinion/position date: 30/04/2020, EC decision date: 06/07/2020, Last updated: 16/11/2020
List item

Referral: Ibuprofen Kabi 400 mg Infusionslösung and associated names

ibuprofen, associated names: Ibuprofen Fresenius Kabi 400 mg oplossing voor infusie, Ibuprofen Fresenius Kabi 400 mg solution pour perfusion, Ibuprofen Kabi, Ibuprofen Kabi 400 mg oldatos infúzió, Ibuprofen Kabi 400 mg soluţie perfuzabilă, Ibuprofen Kabi 400 mg, Ibuprofen Kabi 400 mg raztopina za infundiranje, Ibuprofeno Kabi 400 mg solución para perfusion, Ibuprofen Kabi 400 mg Solution for Infusion, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 23/07/2020, EC decision date: 15/10/2020, Last updated: 26/10/2020
List item

Referral: Panexcell

atazanavir, atazanavir sulfate, Amoxicillin trihydrate, iron sucrose, amoxicillin, azithromycin dihydrate, carbocisteine, trimethoprim, Article 31 referrals
Status: European Commission final decision, opinion/position date: 27/02/2020, EC decision date: 24/09/2020, Last updated: 22/10/2020
List item

Referral: Yondelis

trabectedin, associated names: Yondelis, Article 20 procedures
Status: European Commission final decision, opinion/position date: 24/07/2020, EC decision date: 24/09/2020, Last updated: 09/10/2020
List item

Referral: Budesonide SUN

budesonide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/06/2020, EC decision date: 19/08/2020, Last updated: 16/09/2020
List item

Referral: Leuprorelin-containing depot medicinal products

leuprorelin, associated names: Daronda, Depo-Eligard, Eligard, Eligard Depot, Eligard Mensua, Eligard Semestral, Eligard Trimestral, Elityran 1 Month Depot (Dps), Elityran 3 Month Depot (Dps), Enanton Depot Dual, Enanton Depot Set, Enantone, Enantone L.P, Enantone Lp, Enantone Monats-Depot, Ginecrin Depot, Klebrocid 3-Monats-Depot, Klebrocid Depot Zweikammerspritze, Leptoprol, Lerin, Leugon, Leuprex 3, Leuprol, Leuprolin Ratiopharm, Leuprone 1-Monatsdepot, Leuprone 3-Monatsdepot, Leuprorelin 1-Month Depot Gp-Pharm, Leuprorelin Hexal, Leuprorelin Sandoz, Leuprorelina Gp-Pharm, Leupro-Sandoz 1-Monats-Depot, Leupro-Sandoz 3-Monats-Depot, Leuprorelina Trimestral Sandoz, Leuprostin, Leuproreline Sandoz, Lucrin, Lucrin Depot, Lucrin Pds Depot, Lucrin Pds Depot 1 Maand, Lucrin Pds Depot 3 Maanden, Lucrin Pds Depot 6 Maanden, Lupron Depo, Lutrate 1 Month Depot, Lutrate 3 Month Depot, Lutrate Depo, Lutrate Depot, Lutrate Depot Trimestral, Politrate, Politrate Depot, Procren Depot, Procren Depot Pds, Procrin Mensual, Procrin Semestral, Procrin Trimestral, Prostap 3 Dcs, Prostap 6 Dcs, Prostap Sr Dcs, Prostaplant, Sixantone, Trenantone, Trenantone-Gyn, Zeulide, Елигард, Лутрат Депо, Article 31 referrals
Status: CMDh final position, opinion/position date: 24/06/2020, Last updated: 31/07/2020
List item

Referral: Fluorouracil and fluorouracil related substances (capecitabine, tegafur and flucytosine) containing medicinal products

capecitabine, fluorouracil, tegafur, flucytosine, associated names: Xeloda, Teysuno, Capecitabine Accord, Capecitabine Medac, Capecitabine Teva, Ecansya (previo

3178 results

Referral: Varilrix

Referral: Angiotensin-II-receptor antagonists (sartans) containing a tetrazole group

Referral: Ranitidine-containing medicinal products

Referral: Ulipristal acetate 5mg medicinal products

Referral: Picato

Referral: Ibuprofen Kabi 400 mg Infusionslösung and associated names

Referral: Panexcell

Referral: Yondelis

Referral: Budesonide SUN

Referral: Leuprorelin-containing depot medicinal products

Referral: Fluorouracil and fluorouracil related substances (capecitabine, tegafur and flucytosine) containing medicinal products